On May 28, 2019 CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody therapeutics based on our Probody therapeutic technology platform, reported that Sean McCarthy, D.Phil., president, chief executive officer and chairman, will deliver a corporate overview at the following healthcare conferences in June (Press release, CytomX Therapeutics, MAY 28, 2019, View Source [SID1234536598]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Jefferies 2019 Global Healthcare Conference

Date: Tuesday, June 4, 2019
Time: 10:30 a.m. ET
Location: New York, New York

Goldman Sachs 40th Annual Global Healthcare Conference

Date: Wednesday, June 12, 2019
Time: 2:40 p.m. PT
Location: Rancho Palos Verdes, California
Live audio webcast of these presentations will be available through the "Investors & News" section of CytomX’s website. An archived replay will be available for 90 days following the event.